all signs point to approval done

I think market is not understanding argument against boosters, it’s not that they are not needed, it is that we need to vaccinate more of worlds population with primary doses first, if pandemic left to run rampant it will increase mutations and variants. We need a cost effective , easy to store and transport vaccine, the WHO knows this,NVAX will be a big part of this. Of course always dependent on approval. But looking at published data and listening to company updates, as well as multiple very large orders, all signs point to approval done$Novavax(NVAX)$